Skip to Main Content
Table 1

Normal cells and tumor cell lines used in this study

CellsHLA-A2expressionap53 statusbp53264–272 presentation
Tumors    
 HR mm/codon 306c ND 
 MCF-7 wtd 
 SCC-4 mm/codon 155e − 
 SCC-9 Deletion 275–285e 
 OSC-19 mm/codon 225 ND 
 PCI-4B − wt − 
 PCI-13 mm/codon 286 
 PCI-30 wt ND 
Normal cells    
 PHA-lymphoblasts wt − 
CellsHLA-A2expressionap53 statusbp53264–272 presentation
Tumors    
 HR mm/codon 306c ND 
 MCF-7 wtd 
 SCC-4 mm/codon 155e − 
 SCC-9 Deletion 275–285e 
 OSC-19 mm/codon 225 ND 
 PCI-4B − wt − 
 PCI-13 mm/codon 286 
 PCI-30 wt ND 
Normal cells    
 PHA-lymphoblasts wt − 
a

HLA-A2 expression was determined serologically.

b

Based on sequence analysis of reverse transcription-PCR products corresponding to p53 exons 5–8, as detailed in “Materials and Methods” or in the cited references.

c

mm, missense mutation; wt, wild-type sequence; ND, not determined.

d

Based on the analysis detailed in Ref. 20.

e

Based on the analysis detailed in Ref. 19.

Close Modal

or Create an Account

Close Modal
Close Modal